BDNF가 ADHD의 병인과 치료에 미치는 영향 = Association between the Brain-Derived Neurotropic Factor and Attention Deficit Hyperactivity Disorder

다국어 초록 (Multilingual Abstract)

Attention deficit hyperactivity disorder (ADHD) is a common childhood psychiatric disorder. Recently, it has been suggested that brain-derived neurotropic factor (BDNF) may play a role in the pathogenesis of ADHD. Our aim of this review is to understand the physiological functions of BDNF and its potential relationship with ADHD and therapeutic approaches of ADHD. Searches were conducted in Pubmed and Research Information Service System (RISS). In this review, we summarized important literatures for the physiological functions of BDNF in neurodevelopment, change of serum BDNF level in ADHD, association of BDNF polymorphism and ADHD and potential association of treatment of ADHD with serum BDNF level. Further studies are required to more clearly understand the source and the role of BDNF in ADHD and to develop BDNF based-ADHD treatement.

참고문헌 (Reference)

1 Chen ZY, "Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wildtype BDNF in neurosecretory cells and cortical neurons" 24 : 4401-4411, 2004

2 Kim BN, "Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children" 14 : 1399-1410, 2011

3 Park S, "The role of the brain-derived neurotrophic factor genotype and parenting in early life in predicting externalizing and internalizing symptoms in children with attention-deficit hyperactivity disorder" 10 : 43-, 2014

4 Liu DY, "The physiology of BDNF and its relationship with ADHD" 52 : 1467-1476, 2015

5 Traver S, "The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway" 70 : 30-40, 2006

6 Franke B, "The genetics of attention deficit/hyperactivity disorder in adults, a review" 17 : 960-987, 2012

7 Gunnar MR, "The brain-derived neurotrophic factor Val66Met polymorphism moderates early deprivation effects on attention problems" 24 : 1215-1223, 2012

8 Egan MF, "The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function" 112 : 257-269, 2003

9 Bergman O, "Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity" 14 : 1367-1376, 2011

10 Ortega-Rojas J, "Study of genetic variants in the BDNF, COMT, DAT1 and SERT genes in Colombian children with attention deficit disorder" 46 : 222-228, 2017

11 Li H, "Sex-specific association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and plasma BDNF with attention-deficit/hyperactivity disorder in a drug-naive Han Chinese sample" 217 : 191-197, 2014

12 Bilgic A, "Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder" 26 : 355-363, 2017

13 Akay AP, "Serum brain-derived neurotrophic factor levels in treatment-naive boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study" 27 : 127-135, 2018

14 Scassellati C, "Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD)" 23 : 173-177, 2014

15 Rosenfeld RD, "Purification and identification of brain-derived neurotrophic factor from human serum" 6 : 465-471, 1995

16 Leo D, "Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats" 38 : 1959-1972, 2018

17 Zhang J, "Peripheral brain-derived neurotrophic factor in attention-deficit/hyperactivity disorder: a comprehensive systematic review and meta-analysis" 227 : 298-304, 2018

18 Schimmelmann BG, "No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD" 114 : 523-526, 2007

19 Conner AC, "Neurotrophic factor-related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high-risk male population" 147B : 1476-1480, 2008

20 Maisonpierre PC, "NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression" 5 : 501-509, 1990

21 Faraone SV, "Molecular genetics of attention-deficit/hyperactivity disorder" 57 : 1313-1323, 2005

22 Chase T, "Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum" 144 : 969-984, 2007

23 Sanchez-Mora C, "Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations" 153B : 512-523, 2010

24 Trajkovska V, "Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data" 73 : 143-149, 2007

25 Shim SH, "Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD)" 32 : 1824-1828, 2008

26 Narita M, "Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine" 119 : 767-775, 2003

27 Gainetdinov RR, "Genetics of childhood disorders: XXIV. ADHD, part 8: hyperdopaminergic mice as an animal model of ADHD" 40 : 380-382, 2001

28 조수철, "Gender-Specific Association of the Brain-Derived Neurotrophic Factor Gene with Attention-Deficit/Hyperactivity Disorder" 대한신경정신의학회 7 (7): 285-290, 2010

29 Tzang RF, "Family-based association of the brain-derived neurotrophic factor gene in attentiondeficit hyperactivity disorder" 23 : 177-178, 2013

30 Simsek S, "Evaluation of the relationship between brain-derived neurotropic factor levels and the stroop interference effect in children with attentiondeficit hyperactivity disorder" 53 : 348-352, 2016

31 Sargin E, "Evaluation of serum brain-derived neurotrophic factor levels in children with attention deficit hyperactivity disorder: preliminary data" 49 : 96-101, 2012

32 Monteggia LM, "Essential role of brain-derived neurotrophic factor in adult hippocampal function" 101 : 10827-10832, 2004

33 Horger BA, "Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor" 19 : 4110-4122, 1999

34 Cho SC, "Effect of ADRA2A and BDNF gene-gene interaction on the continuous performance test phenotype" 21 : 132-135, 2011

35 Del'Guidice T, "Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice" 231 : 109-122, 2014

36 Corominas-Roso M, "Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder" 16 : 1267-1275, 2013

37 Pillai A, "Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology" 13 : 535-539, 2010

38 Patros CH, "Choice-impulsivity in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): a meta-analytic review" 43 : 162-174, 2016

39 Ramos-Quiroga JA, "Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine" 231 : 1389-1395, 2014

40 Amiri A, "Changes in plasma brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with attention deficit-hyperactivity disorder (ADHD)" 47 : 20-24, 2013

41 Hariri AR, "Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance" 23 : 6690-6694, 2003

42 Meredith GE, "Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration" 949 : 218-227, 2002

43 Saadat F, "Brain-derived neurotrophic factor as a biomarker in children with attention deficit-hyperactivity disorder" 4 : 10-17, 2015

44 Martin-Iverson MT, "Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine" 14 : 1262-1270, 1994

45 Onder Ozturk, "Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism Is a Risk Factor for Attention-Deficit Hyperactivity Disorder in a Turkish Sample" 대한신경정신의학회 13 (13): 518-525, 2016

46 Rapoport JL, "Brain neuroplasticity in healthy, hyperactive and psychotic children: insights from neuroimaging" 33 : 181-197, 2008

47 Klein AB, "Blood BDNF concentrations reflect brain-tissue BDNF levels across species" 14 : 347-353, 2011

48 Kernie SG, "BDNF regulates eating behavior and locomotor activity in mice" 19 : 1290-1300, 2000

49 Hyman C, "BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra" 350 : 230-232, 1991

50 Cubero-Millan I, "BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology" 234 : 267-279, 2017

51 Lee YH, "BDNF 196 G/A and COMT Val158Met polymorphisms and susceptibility to ADHD: a meta-analysis" 2015

52 Tsai SJ, "Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications" 68 : 896-899, 2007

53 Tsai SJ, "Attention-deficit hyperactivity disorder and brain-derived neurotrophic factor: a speculative hypothesis" 60 : 849-851, 2003

54 박준헌, "Atomoxetine alleviates the symptoms of attention deficit hyperactivity disorder (ADHD) through enhancing of dopamine synthesis and neuronal activity in rats" 경희대학교 대학원 2010

55 Lee J, "Association study of the brain-derived neurotropic factor (BDNF) gene in attention deficit hyperactivity disorder" 144B : 976-981, 2007

56 Ribases M, "Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder" 63 : 935-945, 2008

57 Kent L, "Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD" 10 : 939-943, 2005

58 Yeom CW, "Association of peripheral BDNF level with cognition, attention and behavior in preschool children" 10 : 10-, 2016

59 Simchon-Tenenbaum Y, "Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administration" 282 : 125-132, 2015

60 Lasky-Su J, "A study of how socioeconomic status moderates the relationship between SNPs encompassing BDNF and ADHD symptom counts in ADHD families" 37 : 487-497, 2007